H Knoop1, K van Kessel, R Moss-Morris. 1. Expert Centre for Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Abstract
BACKGROUND:Chronic fatigue is a common symptom of multiple sclerosis (MS). A randomized controlled trial (RCT) showed that cognitive behavioural therapy (CBT) was more effective in reducing MS fatigue than relaxation training (RT). The aim of the current study was to analyse additional data from this trial to determine whether (1) CBT compared to RT leads to significantly greater changes in cognitions and behaviours hypothesized to perpetuate MS fatigue; (2) changes in these variables mediate the effect of CBT on MS fatigue; and (3) these mediation effects are independent of changes in mood. METHOD:Seventy patients (CBT, n=35; RT, n=35) completed theCognitive and Behavioural Responses to Symptoms Questionnaire (CBSQ), the Brief Illness Perception Questionnaire (B-IPQ) modified to measure negative representations of fatigue, the Hospital Anxiety and Depression Scale (HADS), and the Chalder Fatigue Questionnaire (CFQ), pre- and post-therapy. Multiple mediation analysis was used to determine which variables mediated the change in fatigue. RESULTS:Avoidance behaviour and three cognitive variables (symptom focusing, believing symptoms are a sign of damage and a negative representation of fatigue) improved significantly more in the CBT than the RT group. Mediation analysis showed that changing negative representations of fatigue mediated the decrease in severity of fatigue. Change in anxiety covaried with reduction in fatigue but the mediation effect for negative representations of fatigue remained when controlling for improvements in mood. CONCLUSIONS: Change in beliefs about fatigue play a crucial role in CBT for MS fatigue. These beliefs and the role of anxiety deserve more attention in the further development of this intervention.
RCT Entities:
BACKGROUND:Chronic fatigue is a common symptom of multiple sclerosis (MS). A randomized controlled trial (RCT) showed that cognitive behavioural therapy (CBT) was more effective in reducing MS fatigue than relaxation training (RT). The aim of the current study was to analyse additional data from this trial to determine whether (1) CBT compared to RT leads to significantly greater changes in cognitions and behaviours hypothesized to perpetuate MS fatigue; (2) changes in these variables mediate the effect of CBT on MS fatigue; and (3) these mediation effects are independent of changes in mood. METHOD: Seventy patients (CBT, n=35; RT, n=35) completed the Cognitive and Behavioural Responses to Symptoms Questionnaire (CBSQ), the Brief Illness Perception Questionnaire (B-IPQ) modified to measure negative representations of fatigue, the Hospital Anxiety and Depression Scale (HADS), and the Chalder Fatigue Questionnaire (CFQ), pre- and post-therapy. Multiple mediation analysis was used to determine which variables mediated the change in fatigue. RESULTS: Avoidance behaviour and three cognitive variables (symptom focusing, believing symptoms are a sign of damage and a negative representation of fatigue) improved significantly more in the CBT than the RT group. Mediation analysis showed that changing negative representations of fatigue mediated the decrease in severity of fatigue. Change in anxiety covaried with reduction in fatigue but the mediation effect for negative representations of fatigue remained when controlling for improvements in mood. CONCLUSIONS: Change in beliefs about fatigue play a crucial role in CBT for MS fatigue. These beliefs and the role of anxiety deserve more attention in the further development of this intervention.
Authors: Anne Arewasikporn; Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Dawn M Ehde Journal: Health Psychol Date: 2018-04-19 Impact factor: 4.267
Authors: Alison M Mackay; Robert Buckingham; Raymond S Schwartz; Suzanne Hodgkinson; Roy G Beran; Dennis J Cordato Journal: Int J MS Care Date: 2015 May-Jun
Authors: Joseph Chilcot; Rona Moss-Morris; Micol Artom; Larissa Harden; Federica Picariello; Hector Hughes; Sarah Bates; Iain C Macdougall Journal: Int J Behav Med Date: 2016-06
Authors: Kelly A Hyland; Ashley M Nelson; Sarah L Eisel; Aasha I Hoogland; Javier Ibarz-Pinilla; Kendra Sweet; Paul B Jacobsen; Hans Knoop; Heather S L Jim Journal: Ann Behav Med Date: 2022-02-11
Authors: Torsten Sauder; Philipp M Keune; Roy Müller; Thomas Schenk; Patrick Oschmann; Sascha Hansen Journal: BMC Neurol Date: 2021-03-16 Impact factor: 2.474
Authors: Juliane Menting; Stephanie Nikolaus; Jan-Frederic Wiborg; Ellen Bazelmans; Martine M Goedendorp; Arianne C van Bon; Joop P van den Bergh; Marc J T M Mol; Cees J Tack; Hans Knoop Journal: Trials Date: 2015-06-06 Impact factor: 2.279
Authors: Stephan P Keijmel; Corine E Delsing; Tom Sprong; Gijs Bleijenberg; Jos W M van der Meer; Hans Knoop; Chantal P Bleeker-Rovers Journal: BMC Infect Dis Date: 2013-03-27 Impact factor: 3.090